P16INK4a-positive primary tumors had cancer nests less infiltrated with adaptive immune effectors: CD8+ (p=0.032), CD4+ (p=0.016) T lymphocytes as well as GZB+ cells (indicating combined cytolytic power of innate and adaptive TILs) (p=0.007). The gene discussed is CDKN2A; the disease is cancer.